Table 1 Idiopathic short stature treated with GH, non-familial short stature (NFSS) & familial short stature (FSS)
| Â | NFSS Mean (SD) | FSS Mean (SD) | Reference mean (SD) | ||
|---|---|---|---|---|---|
Characteristic | Males (#47) | Females (#16) | Males (#21) | Females (#4) | Normal |
Age start – yr | 11.96 (3.50) | 12.08 (1.39) | 11.96 (2.81) | 12.07 (0.88) |  |
BA start – yr | 9.00 (3.20) | 9.39 (1.51) | 9.10 (2.91) | 10.30 (1.38) |  |
GH stim peak mean | 12.4 | 10.8 | 13.1 | 14.8 | >7Â ng/ml |
range – ng/ml | 7.04 to 28.0 | 7.0 to 19.8 | 7.1 to 38.5 | 8.8 to 20.9 | >7 ng/ml |
GH Freq Samp 12  | 2.53 (1.08) (#31) |  | 2.49 (1.46) (#11) |  | M = 2.54 (0.84) |
hr mean ng/ml |  | 1.78 (0.64) (#8) |  | 3.02 (#1) | F = 1.96 (0.85) |
SMC – U/ml | 0.79 (0.43) (#27) | 0.87 (0.22) (#6) | 1.09 (0.60) (#11) | 1.55 (0.04) (#2) | T-I = 1.04 (0.66) |
IGF-1 – ng/ml | 144 (101) (#19) | 166 (63) (#10) | 158 (69) (#11) | 205 (9) (#2) | T-I = 109–485 |
T-II = 174-512 | |||||
Duration Rx – yr | 5.21 (2.69) | 3.59 (0.94) | 5.30 (2.30) | 3.17 (0.88) |  |